Therapeutic Areas Doctors & Pharmacists

Infectiology

We are there for you when it counts!

Innovative antibiotics are crucial when things get serious.
Just like the responsible and conscious use of them!

Antibiotics can save lives and should be used appropriately to maintain their effectiveness and slow down the emergence of new resistance. When patients need them, the benefits outweigh the risks of side effects and the potential for resistance to develop.

As older antibiotics increasingly lose their effectiveness due to the rise in resistance, treatment options for effective treatment of multidrug-resistant infections are diminishing. In  December 2019, only 12 antibiotics were in late-stage development, of which only a few will achieve approval to treat patients. In contrast, more than 700 oncology molecules are in late-stage development. If this trend  continues, the arsenal for combating resistant bacteria will soon be exhausted. Faced with this situation, A. Menarini Pharma has decided to play a significant role in the fight against antimicrobial resistance (AMR) and has added three innovative antibiotics to its product portfolio.

To further strengthen its commitment to providing effective and innovative solutions for thetreatment of resistant infections, A. Menarini Pharma has become an active partner in the partner of the AMR Action Fund along with other leading pharmaceutical companies. The goal of this collaboration is to make available by the end of 2030 two to four innovative antibiotics to patients by the end of 2030 and to support antibiotic research and development with resources, knowledge and expertise from industry. This unique platform, in collaboration with its strategic partners, will facilitate the policy reforms necessary to ensure adequate investment in antibiotics research and development. "Infection in Focus" was created by A. Menarini Pharma with the aim of raising awareness about AMR and combat life-threatening bacterial infections, which are a growing global threat.

How does A. Menarini Pharma support the cause?

• A. Menarini Pharma is committed to the development, commercialization and access to new antibiotics 
  A. Menarini Pharma is there for you and your patients when it matters!
• A. Menarini Pharma strives to combat resistant infections and reduce morbidity and mortality rates
• A. Menarini Pharma supports the responsible use of antibiotics through global antimicrobial stewardship programs based on providing the right antibiotic to the right patient at the right time
• Providing meaningful clinical and health economic evidence to relevant stakeholders to inform treatment decisions and pathways

AT-WEB-14-11-2023